Celon Pharma S.A. (CLN.WA)

PLN 24.05

(-1.84%)

EBITDA Summary of Celon Pharma S.A.

Celon Pharma S.A.'s latest annual EBITDA in 2023 was 32.71 Million PLN , up 141.77% from previous year.
Celon Pharma S.A.'s latest quarterly EBITDA in 2024 Q2 was 8.46 Million PLN , up 130.33% from previous quarter.
Celon Pharma S.A. reported an annual EBITDA of 9.32 Million PLN in 2022, down -66.18% from previous year.
Celon Pharma S.A. reported an annual EBITDA of 27.8 Million PLN in 2021, down -59.12% from previous year.
Celon Pharma S.A. reported a quarterly EBITDA of 8.46 Million PLN for 2024 Q2, up 130.33% from previous quarter.
Celon Pharma S.A. reported a quarterly EBITDA of 2.45 Million PLN for 2023 Q3, down -89.73% from previous quarter.

Annual EBITDA Chart of Celon Pharma S.A. (2023 - 2012)

Historical Annual EBITDA of Celon Pharma S.A. (2023 - 2012)

Year	EBITDA	EBITDA Growth
2023	32.71 Million PLN	141.77%
2022	9.32 Million PLN	-66.18%
2021	27.8 Million PLN	-59.12%
2020	30.37 Million PLN	142.34%
2019	26.83 Million PLN	-49.73%
2018	55.85 Million PLN	14.42%
2017	48.53 Million PLN	-19.93%
2016	60.82 Million PLN	12.46%
2015	55.05 Million PLN	56.97%
2014	34.36 Million PLN	30.73%
2013	26.28 Million PLN	295.01%
2012	6.65 Million PLN	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	-9.09 Million PLN	-253.22%
2024 Q2	8.46 Million PLN	130.33%
2023 Q3	2.45 Million PLN	-89.73%
2023 Q1	-1.91 Million PLN	-133.32%
2023 FY	- PLN	141.77%
2023 Q2	23.93 Million PLN	1350.08%
2023 Q4	4.11 Million PLN	67.14%
2022 Q2	3.6 Million PLN	530.47%
2022 Q1	571 Thousand PLN	0.35%
2022 FY	- PLN	-66.18%
2022 Q4	5.74 Million PLN	777.56%
2022 Q3	655 Thousand PLN	-81.81%
2021 Q3	7.69 Million PLN	-38.07%
2021 FY	- PLN	-59.12%
2021 Q4	569 Thousand PLN	-92.61%
2021 Q1	9.82 Million PLN	-58.74%
2021 Q2	12.42 Million PLN	26.56%
2020 Q2	12.29 Million PLN	-15.59%
2020 Q1	14.56 Million PLN	260.0%
2020 Q4	23.79 Million PLN	153.49%
2020 FY	- PLN	142.34%
2020 Q3	9.38 Million PLN	-23.62%
2019 Q3	6.76 Million PLN	31.87%
2019 Q1	11.98 Million PLN	-15.63%
2019 Q2	5.13 Million PLN	-57.19%
2019 FY	- PLN	-49.73%
2019 Q4	4.04 Million PLN	-40.24%
2018 Q3	13.61 Million PLN	-6.3%
2018 Q2	14.52 Million PLN	9.89%
2018 Q1	13.22 Million PLN	-18.24%
2018 Q4	14.21 Million PLN	4.4%
2018 FY	- PLN	14.42%
2017 Q4	16.17 Million PLN	73.45%
2017 Q3	9.32 Million PLN	-31.66%
2017 FY	- PLN	-19.93%
2017 Q2	13.64 Million PLN	44.61%
2017 Q1	9.43 Million PLN	-5.41%
2016 Q2	13.57 Million PLN	-34.97%
2016 FY	- PLN	12.46%
2016 Q4	9.97 Million PLN	-13.88%
2016 Q1	20.87 Million PLN	-28.51%
2016 Q3	11.58 Million PLN	-14.68%
2015 Q4	29.19 Million PLN	435.46%
2015 FY	- PLN	56.97%
2015 Q3	5.45 Million PLN	0.0%
2014 FY	- PLN	30.73%
2013 FY	- PLN	295.01%
2012 FY	- PLN	0.0%

Peer EBITDA Comparison of Celon Pharma S.A.

Name	EBITDA	EBITDA Difference